KAREN LUKEN: Open Payments
NPI 1942469960 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 7 payments from 5 companies in 2025. Trend: 2023 $353 · 2024 $397 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $111 |
| Novo Nordisk Inc | 1 | $100 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| Gilead Sciences, Inc. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 3 | $17 |
Products named: REZDIFFRA, Wegovy, ZENPEP, Livdelzi, VOQUEZNA.
Industry payments across IA — which companies pay providers there.
